Israel Englander Liva Nova PLC Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Liva Nova PLC stock. As of the latest transaction made, Millennium Management LLC holds 40,100 shares of LIVN stock, worth $2.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,100

Previous 10,000 301.0%

Holding current value

$2.45 Million

Previous $517,000 333.85%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$48.6 - $57.12 $4.39 Million - $5.17 Million	90,426 Added 4.13%	2,278,961 $127 Million
Q4 2023 Feb 14, 2024	BUY	$43.45 - $53.66 $39.3 Million - $48.5 Million	903,840 Added 70.35%	2,188,535 $113 Million
Q2 2023 Aug 14, 2023	SELL	$42.28 - $51.43 $7.57 Million - $9.21 Million	-179,021 Reduced 12.23%	1,284,695 $66.1 Million
Q1 2023 May 15, 2023	BUY	$40.84 - $58.14 $30.3 Million - $43.2 Million	743,103 Added 103.12%	1,463,716 $63.8 Million
Q4 2022 Feb 14, 2023	SELL	$43.88 - $56.16 $13.8 Million - $17.7 Million	-315,512 Reduced 30.45%	720,613 $40 Million

Q3 2022 Nov 14, 2022	SELL	$48.37 - $66.5 $33 Million - $45.4 Million	-683,141 Reduced 39.73%	1,036,125 $52.6 Million
Q2 2022 Aug 15, 2022	BUY	$57.25 - $86.63 $15.2 Million - $23 Million	265,085 Added 18.23%	1,719,266 $107 Million
Q1 2022 May 16, 2022	BUY	$71.02 - $86.99 $3.81 Million - $4.66 Million	53,616 Added 3.83%	1,454,181 $119 Million
Q4 2021 Feb 14, 2022	BUY	$76.72 - $92.68 $170,702 - $206,213	2,225 Added 0.16%	1,400,565 $122 Million
Q3 2021 Nov 15, 2021	BUY	$76.02 - $88.62 $64 Million - $74.6 Million	842,305 Added 151.48%	1,398,340 $111 Million
Q2 2021 Aug 16, 2021	BUY	$73.44 - $87.01 $10.3 Million - $12.2 Million	140,381 Added 33.77%	556,035 $46.8 Million
Q1 2021 May 17, 2021	SELL	$62.9 - $82.41 $13.4 Million - $17.5 Million	-212,263 Reduced 33.8%	415,654 $30.6 Million
Q4 2020 Feb 16, 2021	BUY	$46.01 - $68.74 $23 Million - $34.4 Million	500,728 Added 393.69%	627,917 $41.6 Million
Q3 2020 Nov 16, 2020	SELL	$41.91 - $57.81 $1.18 Million - $1.63 Million	-28,273 Reduced 18.19%	127,189 $5.75 Million
Q2 2020 Aug 14, 2020	SELL	$39.87 - $56.9 $672,527 - $959,789	-16,868 Reduced 9.79%	155,462 $7.48 Million
Q1 2020 May 14, 2020	BUY	$34.22 - $76.49 $5.77 Million - $12.9 Million	168,746 Added 4708.31%	172,330 $7.8 Million
Q4 2019 Feb 14, 2020	SELL	$68.92 - $85.27 $21.7 Million - $26.8 Million	-314,807 Reduced 98.87%	3,584 $270,000
Q3 2019 Nov 14, 2019	BUY	$71.74 - $86.35 $18.3 Million - $22 Million	255,321 Added 404.82%	318,391 $23.5 Million
Q2 2019 Aug 15, 2019	BUY	$66.45 - $97.36 $3.3 Million - $4.84 Million	49,689 Added 371.34%	63,070 $4.54 Million
Q2 2019 Aug 14, 2019	SELL	$66.45 - $97.36 $25 Million - $36.6 Million	-375,891 Reduced 96.56%	13,381 $90,000
Q1 2019 May 14, 2019	BUY	$86.15 - $100.49 $31.1 Million - $36.3 Million	361,346 Added 1293.94%	389,272 $37.9 Million
Q4 2018 Feb 14, 2019	SELL	$84.14 - $125.42 $15.4 Million - $22.9 Million	-182,658 Reduced 86.74%	27,926 $2.55 Million
Q3 2018 Nov 14, 2018	SELL	$101.02 - $130.95 $53.2 Million - $69 Million	-527,073 Reduced 71.45%	210,584 $26.1 Million
Q2 2018 Aug 14, 2018	BUY	$81.75 - $105.37 $1.65 Million - $2.13 Million	20,179 Added 2.81%	737,657 $73.6 Million
Q1 2018 May 15, 2018	BUY	$79.95 - $89.74 $17.9 Million - $20.1 Million	224,035 Added 45.4%	717,478 $63.5 Million
Q4 2017 Feb 14, 2018	BUY	$71.8 - $88.21 $34.9 Million - $42.9 Million	485,840 Added 6390.11%	493,443 $39.4 Million
Q3 2017 Nov 14, 2017	BUY	$60.32 - $70.06 $458,612 - $532,666	7,603	7,603 $533,000

Others Institutions Holding LIVN

# of Institutions

253

Shares Held

56.2M

Call Options Held

367K

Put Options Held

597K

View Full List

About LivaNova PLC

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $3.27B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

More about LIVN

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account